drugset / Trial / NCT05157113

Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population

NCT05157113

Phase 4 Recruiting 70 enrolled University of California, San Francisco
RandomizedCrossoverSingle-blindPrevention

Summary

The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.

Timeline

Start
2022-05-31
Primary completion
2026-06-01
Completion
2026-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 0.5 % Topical
Comparator Neomycin Unknown Topical
Comparator Polymyxin B Peptide Topical
Comparator Prednisolone Other / unclassified 1 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 20 mg Other
Comparator Cefuroxime Small molecule Other

Indications